Amyloid-related imaging abnormalities (ARIA): diagnosis, management, and care in the setting of amyloid-modifying therapy. — Amyloid-related imaging abnormalities, were originally described by dementia care experts. The wider use of aducanumab and now lecanemab warrant broader understanding by the health care...

Evidence span

Amyloid-related imaging abnormalities (ARIA): diagnosis, management, and care in the setting of amyloid-modifying therapy. — Amyloid-related imaging abnormalities, were originally described by dementia care experts. The wider use of aducanumab and now lecanemab warrant broader understanding by the health care...

From Vukmir RB 2024, Annals of clinical and translational neurology

Method & conditions

Evidence type

experimental

Method

manual state transition; control details require source inspection

Species

Homo sapiens

Conditions

Humans; Alzheimer Disease; Disease Management; Amyloid beta-Peptides; Antibodies, Monoclonal, Humanized — Annals of clinical and translational neurology 2024

Replicated

not yet

Confidence basis

operator-supplied frontier prior; review required